A drug can change cell behavior through a different target from the one proposed. Complementary experiments help establish which mechanism actually caused the effect.
Primary genetic interrogation of selected cancer drugs found examples in which cell-killing activity persisted after loss of the proposed target. The study illustrates why pharmacological response alone is insufficient to establish a cancer dependency. Genetic perturbation, complementary compounds, suitable controls and target-engagement measurements address different parts of the claim. Agreement strengthens a mechanism within the tested system; it does not establish a safe or effective treatment in people.
Showing the technology this term belongs to: CRISPR functional genomics.
Shares Drug target engagement, Evidence from measurement to patient benefit.
Shares Drug target engagement, Evidence from measurement to patient benefit.
Shares Functional evidence for a sequence variant, Evidence from measurement to patient benefit.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/